ЭКСТРАКТЫ ЩИТОВИДНОЙ ЖЕЛЕЗЫ ЖИВОТНЫХ И КОМБИНИРОВАННАЯ ТЕРАПИЯ ТИРОКСИНОМ И ТРИЙОДТИРОНИНОМ: ОФИЦИАЛЬНАЯ ПОЗИЦИЯ ИСПОЛНИТЕЛЬНОГО КОМИТЕТА БРИТАНСКОЙ ТИРЕОИДНОЙ АССОЦИАЦИИ

1. An FDA enforcement removed more than half a million bottles of Armour Thyroid from US pharmacies in 2005 due to unstable concentrations of thyroid hormone in the preparation. www.fda.gov/bbs/topics/enforce/2005/ENF00899.html

2. Bunevicius R., Kazanavicius G., Zalinkevicius R., Prange A.J. Jr. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism // N. Engl. J. Med. 1999. N 340. P. 424-429.

3. Escobar-Morreale H.F., Botella-Carretero J.I., Escobar del Rey F. et al. Review: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine // J. Clin. Endocrinol. Metab. 2005. N 90. P. 4946-4954.

4. Grozinsky-Glasberg S., Fraser A., Nahshoni E. et al. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials // J. Clin. Endocrinol. Metab. 2006. N 91. P. 2592-2599.